In addition, the observed lineage switch from ALL to AML is consistent with clinical data [51], where B-ALL is mostly found in pediatric patients with the KMT2A::ENL translocation and lineage switching is observed during the relapse [20]. This evidence concerns the gene MLLT1 and acute myeloid leukemia.